TASE to expand MidCap 30 to 50

The TASE said Sunday it will expand its MidCap-30 index to a MidCap-50 effective as of July 1, The move, which will allow the exchange to list the 50 companies with the highest market cap that aren't big enough to trade on the TA-100

By MATTHEW KRIEGER
May 21, 2007 07:44

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The Tel Aviv Stock Exchange said Sunday it will expand its MidCap-30 index to a MidCap-50 effective as of July 1, The move, which will allow the exchange to list the 50 companies with the highest market cap that aren't big enough to trade on the TA-100, comes in response to the large number of companies that made initial public offerings over the past two years, as well as in the hopes of boosting turnover in lower-tier stocks, the TASE said. The changes will come into effect the next time the TASE updates its indexes.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS